Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.

School bullying correlates with depression and internet addiction, but emotional resilience serves as a protective factor for adolescents.

The US Department of Health and Human Services Office of Inspector General reports on significant denial rates for post-hospital care.

Standardized diagnostic interviews show moderate-to-substantial test-retest reliability for adult psychiatric and substance use disorders.

Social determinants of health are associated with neurobiologic abnormalities in schizophrenia-spectrum psychotic conditions.

Patient portals and other virtual health care options are expanding, with notable growth in patient portal messaging between 2020 and 2025.

Viloxazine extended-release shows promise for treating adults with ADHD who also experience symptoms of depression and anxiety.

Long-term eptinezumab treatment provides sustained reductions in headache burden for patients with highly refractory chronic migraine.

Self-reported interpersonal trauma correlates with increased cognitive disengagement syndrome symptoms in young adolescents.

Nonmedical use of ADHD stimulants by adults is frequently motivated by a desire to improve concentration or stay alert and is often associated with other substance use disorders.

About a fourth of teens and adults with Tourette syndrome or another tic disorder have attempted suicide at some point in their lives.

Childhood inattentive ADHD symptoms are associated with adverse occupational outcomes and higher stress levels in adulthood.